Harvard Bioscience, Inc. (HBIO)
NASDAQ: HBIO · Real-Time Price · USD
5.34
+0.07 (1.33%)
At close: Mar 23, 2026, 4:00 PM EDT
5.34
0.00 (0.00%)
After-hours: Mar 23, 2026, 4:10 PM EDT
Harvard Bioscience Market Cap
Harvard Bioscience has a market cap or net worth of $238.8 million as of March 23, 2026. Its market cap has increased by 559.68% in one year.
Market Cap
238.80M
Enterprise Value
271.34M
1-Year Change
559.68%
Ranking
Category
Stock Price
$5.34
Market Cap Chart
Since March 19, 2001, Harvard Bioscience's market cap has increased from $173.50M to $238.80M, an increase of 37.64%. That is a compound annual growth rate of 1.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 23.60M | -20.81% |
| Dec 31, 2025 | 29.80M | -67.61% |
| Dec 31, 2024 | 92.00M | -59.72% |
| Dec 29, 2023 | 228.40M | 97.92% |
| Dec 30, 2022 | 115.40M | -59.89% |
| Dec 31, 2021 | 287.70M | 72.07% |
| Dec 31, 2020 | 167.20M | 44.01% |
| Dec 31, 2019 | 116.10M | -2.11% |
| Dec 31, 2018 | 118.60M | 3.04% |
| Dec 29, 2017 | 115.10M | 9.83% |
| Dec 30, 2016 | 104.80M | -11.04% |
| Dec 31, 2015 | 117.80M | -35.91% |
| Dec 31, 2014 | 183.80M | 26.15% |
| Dec 31, 2013 | 145.70M | 15.45% |
| Dec 31, 2012 | 126.20M | 14.42% |
| Dec 30, 2011 | 110.30M | -4.42% |
| Dec 31, 2010 | 115.40M | 9.70% |
| Dec 31, 2009 | 105.20M | 29.08% |
| Dec 31, 2008 | 81.50M | -42.24% |
| Dec 31, 2007 | 141.10M | -9.96% |
| Dec 29, 2006 | 156.70M | 15.56% |
| Dec 30, 2005 | 135.60M | -3.49% |
| Dec 31, 2004 | 140.50M | -47.56% |
| Dec 31, 2003 | 267.90M | 170.88% |
| Dec 31, 2002 | 98.90M | -62.67% |
View and export this data all the way back to 2001. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Anteris Technologies Global | 544.50M |
| Embecta | 526.46M |
| AngioDynamics | 429.07M |
| Utah Medical Products | 205.93M |
| OraSure Technologies | 203.92M |
| KORU Medical Systems | 195.22M |
| Stereotaxis | 174.08M |
| Microbot Medical | 170.58M |